Published in J Invest Dermatol on June 28, 2007
Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med (2011) 1.74
Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature (2009) 1.71
The role of the inflammasome in nonmyeloid cells. J Clin Immunol (2010) 1.18
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain (2009) 1.17
Differential developmental requirement and peripheral regulation for dermal Vγ4 and Vγ6T17 cells in health and inflammation. Nat Commun (2014) 1.07
Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol (2013) 1.05
NOD-like receptors and inflammation. Arthritis Res Ther (2008) 0.95
Caspase-1 modulates incisional sensitization and inflammation. Anesthesiology (2010) 0.88
IL-27 Regulates IL-18 binding protein in skin resident cells. PLoS One (2012) 0.87
Ribotoxic stress through p38 mitogen-activated protein kinase activates in vitro the human pyrin inflammasome. J Biol Chem (2013) 0.86
The potential for caspases in drug discovery. Curr Opin Drug Discov Devel (2010) 0.86
The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice. EMBO J (2009) 0.83
Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol (2014) 0.79
IL-18 and Cutaneous Inflammatory Diseases. Int J Mol Sci (2015) 0.78
Serum amyloid A induces interleukin-1β secretion from keratinocytes via the NACHT, LRR and PYD domains-containing protein 3 inflammasome. Clin Exp Immunol (2015) 0.78
Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms. Open Biochem J (2014) 0.76
Inflammasomes and dermatology. An Bras Dermatol (2016) 0.75
Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice. PLoS One (2013) 0.75
Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation. PLoS One (2017) 0.75
Signs of innate immune activation and premature immunosenescence in psoriasis patients. Sci Rep (2017) 0.75
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol (2008) 2.37
Tracking drinking behaviour from age 15-19 years. Addiction (2003) 1.68
Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. J Invest Dermatol (2006) 1.59
Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol (2010) 1.51
Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol (2003) 1.30
H-Ras forms dimers on membrane surfaces via a protein-protein interface. Proc Natl Acad Sci U S A (2014) 1.23
The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine (2007) 1.16
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood (2007) 1.14
1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression. Arch Dermatol Res (2004) 1.14
Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol (2003) 1.09
Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol (2006) 1.08
IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms. J Invest Dermatol (2007) 1.04
Cynical hostility, socioeconomic position, health behaviors, and symptom load: a cross-sectional analysis in a Danish population-based study. Psychosom Med (2004) 0.98
Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect. J Invest Dermatol (2007) 0.96
A survey of occupational hand eczema in Denmark. Contact Dermatitis (2004) 0.95
Caspase-5 expression is upregulated in lesional psoriatic skin. J Invest Dermatol (2010) 0.95
MK2 regulates the early stages of skin tumor promotion. Carcinogenesis (2009) 0.95
Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB. J Biol Chem (2011) 0.94
Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma. Toxins (Basel) (2013) 0.91
Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity. Exp Dermatol (2013) 0.91
Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. J Invest Dermatol (2005) 0.90
How does individual smoking behaviour among hospital staff influence their knowledge of the health consequences of smoking? Scand J Public Health (2003) 0.89
Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients. Acta Derm Venereol (2012) 0.88
Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark. Acta Oncol (2011) 0.88
Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis. Exp Dermatol (2011) 0.88
HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. Arch Dermatol (2003) 0.87
Specific and reversible immobilization of histidine-tagged proteins on functionalized silicon nanowires. Nanotechnology (2010) 0.87
National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines. Arch Dermatol Res (2013) 0.87
Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases. Exp Dermatol (2007) 0.87
Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries. Acta Derm Venereol (2013) 0.87
Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB. Cytokine (2005) 0.86
TNFα- and IL-17A-mediated S100A8 expression is regulated by p38 MAPK. Exp Dermatol (2013) 0.86
Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo. Toxicol Pathol (2005) 0.85
Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice. J Invest Dermatol (2008) 0.85
Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model. Cancer Invest (2011) 0.85
Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries. PLoS One (2012) 0.84
Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis. J Invest Dermatol (2007) 0.84
Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists. PPAR Res (2009) 0.84
The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA. PLoS One (2010) 0.84
Signal transduction pathways in human epidermis. Eur J Dermatol (2005) 0.83
The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice. EMBO J (2009) 0.83
Inflammatory cytokines break down intrinsic immunological tolerance of human primary keratinocytes to cytosolic DNA. J Immunol (2014) 0.83
Immunosuppressive therapy in dermatology and PML. J Dtsch Dermatol Ges (2009) 0.83
Psoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severity. Eur J Dermatol (2006) 0.83
The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice. Exp Dermatol (2010) 0.83
New vitamin D analogs in psoriasis. Curr Drug Targets Inflamm Allergy (2004) 0.82
Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate. Acta Derm Venereol (2011) 0.82
Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-kappaB DNA-binding activity. Acta Derm Venereol (2004) 0.81
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment. Dan Med J (2012) 0.80
Quantifying signal changes in nano-wire based biosensors. Nanoscale (2010) 0.80
Juvenile psoriasis and its clinical management: a European expert group consensus. J Dtsch Dermatol Ges (2010) 0.80
Cardiovascular risk factors in children and adolescents with psoriasis: a case-control study. Acta Derm Venereol (2014) 0.79
[Liver cirrhosis mortality. Denmark in an international perspective--what direction are we taking?]. Ugeskr Laeger (2002) 0.79
Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report. Acta Derm Venereol (2013) 0.78
Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin. Exp Dermatol (2014) 0.78
Predicting and rationalizing the effect of surface charge distribution and orientation on nano-wire based FET bio-sensors. Nanoscale (2011) 0.77
Early breastfeeding cessation: validation of a prognostic breastfeeding score. Acta Paediatr (2007) 0.77
IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab. Acta Derm Venereol (2013) 0.77
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment. Int J Dermatol (2006) 0.77
CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways. Cytokine (2011) 0.77
Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977-2006). Am J Clin Dermatol (2012) 0.77
Pegylated liposomal doxorubicin in the treatment of mycosis fungoides. Acta Derm Venereol (2006) 0.76
Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid. Curr Med Res Opin (2009) 0.76
Humicola lanuginosa lipase hydrolysis of mono-oleoyl-rac-glycerol at the lipid-water interface observed by atomic force microscopy. Biochim Biophys Acta (2003) 0.76
Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models. BMC Immunol (2013) 0.75
Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis. Int J Dermatol (2014) 0.75
[Should physicians advise on smoking cessation? What do patients and the general population think?]. Ugeskr Laeger (2004) 0.75
Evaluation of analytical performance assisted by total error criteria of a commercial enzyme immunometric assay for canine serum thyrotropin. Vet Clin Pathol (1999) 0.75
Non-linear mixed effects modeling of sparse concentration data from rats: application to a glycogen phosphorylase inhibitor. Eur J Drug Metab Pharmacokinet (2002) 0.75
Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study. Acta Derm Venereol (2019) 0.75
Growth medium-dependent ERK1/2 and AP-1 activity in cultured normal human keratinocytes modulates 1alpha,25-dihydroxyvitamin D3-induced differentiation. Arch Dermatol Res (2003) 0.75
[Impact of a 10-year nation-wide campaign on knowledge of sensible drinking limits in Denmark]. Ugeskr Laeger (2002) 0.75